What is the difference in access to anti-retroviral drugs, female between Sub-Saharan Africa and United Arab Emirates?

10.7%, with United Arab Emirates ahead.

How many years of comparable data are there for Sub-Saharan Africa and United Arab Emirates?

25 years are reported by both, from 2000 to 2024.

Where does this data come from?

UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Sub-Saharan Africa vs United Arab Emirates: Access to anti-retroviral drugs, female

Sub-Saharan Africa

86.3%

in 2024

United Arab Emirates

97.0%

in 2024

Sub-Saharan Africa rank

10th

United Arab Emirates rank

12th

Access to anti-retroviral drugs, female over time

Sub-Saharan Africa
United Arab Emirates

How they compare

United Arab Emirates currently reports 97.0% against 86.3% in Sub-Saharan Africa, a difference of 10.7%.

That makes United Arab Emirates's figure about 1.1 times Sub-Saharan Africa's.

The two have swapped places 4 times across 25 shared years of data; in 2000 it was United Arab Emirates ahead.

Sub-Saharan Africa ranks 10th and United Arab Emirates ranks 12th of 19 groups.

Across the 3 decades both report, Sub-Saharan Africa averaged higher in 1 and United Arab Emirates in 2.

Head to head by decade

Decade	Sub-Saharan Africa	United Arab Emirates	Difference	Ahead
2000s	5.8%	21.0%	15.2%	United Arab Emirates
2010s	50.9%	31.5%	19.4%	Sub-Saharan Africa
2020s	81.3%	85.4%	4.1%	United Arab Emirates

Averages of every year both report within each decade.

Frequently asked questions

Which has higher access to anti-retroviral drugs, female, Sub-Saharan Africa or United Arab Emirates?: United Arab Emirates, at 97.0% against 86.3% in Sub-Saharan Africa as of 2024.
What is the difference in access to anti-retroviral drugs, female between Sub-Saharan Africa and United Arab Emirates?: 10.7%, with United Arab Emirates ahead.
How many years of comparable data are there for Sub-Saharan Africa and United Arab Emirates?: 25 years are reported by both, from 2000 to 2024.
How do Sub-Saharan Africa and United Arab Emirates rank globally for access to anti-retroviral drugs, female?: Sub-Saharan Africa ranks 10th and United Arab Emirates ranks 12th of 19 groups.
Where does this data come from?: UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Sub-Saharan Africa vs United Arab Emirates: Access to anti-retroviral drugs, female. Statizoid, drawing on UNAIDS estimates. Retrieved 18 September 2026, from https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/sub-saharan-africa/united-arab-emirates/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/sub-saharan-africa/united-arab-emirates/">Sub-Saharan Africa vs United Arab Emirates: Access to anti-retroviral drugs, female</a> — Statizoid

About this data

Indicator: Access to anti-retroviral drugs, female (%)
Unit: %
Source: UNAIDS estimates
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 160 places, 3,925 data points, 2000–2024
Last refreshed: 04 September 2026

The percentage of adult females living with HIV who are receiving antiretroviral therapy.